Sign in

CIK 0002019410 · Non-accelerated filer<br>Emerging growth company

Caris Life Sciences, Inc.

Sign in to watch
Ticker
CAI
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
TX
Entity type
operating
EIN
852077369
Phone
(866) 771-8946
Business address
750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
  1. 4 Open-market sale See Remarks sold 7,500 shares at $31.82 ($238,626)
  2. 4 Open-market sale See Remarks sold 400,000 shares at $30.33 ($12,132,080)
  3. 4 Open-market sale President sold 597,212 shares at an average $24.84 ($14,834,107)
  4. 4 Grant or award Director acquired 13,192 shares (grant or award)
  5. 4 Grant or award Director acquired 13,192 shares (grant or award)
  6. 4 Grant or award Director acquired 13,192 shares (grant or award)
  7. 4 Grant or award Director acquired 13,192 shares (grant or award)
  8. 4 Grant or award Director acquired 13,192 shares (grant or award)
  9. 4 Grant or award Director acquired 13,192 shares (grant or award)
  10. 4 Grant or award Director acquired 13,192 shares (grant or award)
  11. 4 Grant or award Director acquired 13,192 shares (grant or award)
  12. 4 Open-market buy Director bought 68,000 shares at $14.56 ($990,080)
  13. 4 Grant or award Director acquired 1,600 shares (grant or award)
  14. 4 Grant or award Director acquired 1,600 shares (grant or award)
  15. 4 Shares withheld for taxes See Remarks gave up 6,047 shares (to pay taxes)
  16. 4 Shares withheld for taxes See Remarks gave up 9,771 shares (to pay taxes)
  17. 4 Shares withheld for taxes President gave up 13,856 shares (to pay taxes)
  18. 4 Shares withheld for taxes See Remarks gave up 13,987 shares (to pay taxes)
  19. 4 Shares withheld for taxes See Remarks gave up 40,712 shares (to pay taxes)
  20. 4 Open-market buy Director bought 31,050 shares at $16.15 ($501,426)

Page 1 of 4 · 67 filings